For example, Sage et al. demonstrated that oxidized lipids reduced osteogenesis and influenced the bone anabolic effects of parathyroid hormone (PTH) by encouraging bone resorption (Sage et al., 2011), which suggests the resistance to PTH therapy in osteoporotic patients with hyperlipidemia. Here, PTH is linked to hyperlipidemia.